Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-12

Clinical Trial Update: Recurrent Liver Cancer: Reconceptualization and Reevaluation

View source ↗

Summary

Clinical trial update indicates ongoing research reconceptualization and reevaluation of therapies for recurrent and primary liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nanjing Medical University | Conditions: Recurrent Liver Cancer, Primary Liver Cancer | Status: RECRUITING